Whole Genome Sequencing Market Report 2024-2034: Key Player Profiles for Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, Illumina, Thermo Fisher Scientific & ProPhase Labs - ResearchAndMarkets.com
ProPhase Labs Finalizing Set of Cost-saving Measures for Non-core Operations
Pharmaloz Announced Final Contract Negotiations With Major Lozenge Brand; New Partnership Could Add $35M Annually To Revenue By Late 2025, Bringing Total Revenue To $50M With Projected Net Earnings Of $8M-$10M In 2026; Targets $6M Annual Savings...
Express News | Prophase Labs: Finalizing Cost-Saving Measures Targeting Non-Core Ops That Will Reduce Oper Expenses by at Least $6 Mln/Yr
Express News | Prophase Labs: Jay Schwartz Will Assist Co in Pursuing Strategic Alternatives Including a Potential Sale of Pharmaloz
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures
